๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Esophagus Cancer

Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma NCT06342167Phase 210 sites๐Ÿ“ Beijing๐Ÿ“ Fujian๐Ÿ“ Handan Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: Radiotherapy, Programmed Cell Death Protein 1 Inhibitor, Immunonutrition support Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers NCT02584244Phase 1, Phase 21 site๐Ÿ“ Boston Lumicell, Inc. ยท Tests: LUM015, LUM 2.6 Imaging Device Development and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated Gastroscopy NCT07104214n/a3 sites๐Ÿ“ Hangzhou๐Ÿ“ Jiaxing๐Ÿ“ Lishui Zhejiang University Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining NCT00242723n/a1 site๐Ÿ“ Bethesda National Cancer Institute (NCI) A Study of Bemosubaiabimab Combined With Anlotinib and Radiotherapy and Chemotherapy for the Treatment of Oligometastatic Esophageal Cancer NCT07455019Phase 21 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: The treatment group using pembrolizumab combined with anlotinib and radiotherapy and chemotherapy Registry Platform Gastric/Esophageal Cancer (SAPHIR) NCT04290806n/a1 site๐Ÿ“ Multiple Locations iOMEDICO AG ยท Tests: Routine care as per site standard Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients NCT07114627n/a1 site๐Ÿ“ Rotterdam Erasmus Medical Center ยท Tests: Blood sampling for pharmacokinetics Lucid Registry Study NCT05965999n/a1 site๐Ÿ“ Lake Forest Lucid Diagnostics, Inc. ยท Tests: EsoCheckยฎ, EsoGuardยฎ A Trial of the Combination of Afatinib and Palbociclib in Previously Treated Advanced Esophageal Squamous Cell Carcinoma NCT06753747Phase 1, Phase 21 site๐Ÿ“ Chengdu West China Hospital ยท Tests: Palbociclib, Afatinib(30mg), Afatinib(40mg), Afatinib(RP2D) Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study NCT07437898Phase 21 site๐Ÿ“ Putian The Affiliated Hospital of Putian University ยท Tests: Adebrelimab, chemotherapy AI-Assisted Non-Contrast CT for Multi-Cancer Screening NCT06632886NA1 site๐Ÿ“ Shanghai Guo ShiWei ยท Tests: AI-Assisted Non-Contrast CT for Multi-Cancer Screening A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR) NCT06232083Phase 11 site๐Ÿ“ Hefei Anhui Provincial Hospital ยท Tests: PLDR+Cardunizumab Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux NCT06746623NA1 site๐Ÿ“ Cleveland Louis Stokes VA Medical Center ยท Tests: Enrolled participants will complete Esocheck/Esoguard and diagnostic upper endoscopy. Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer NCT06173986Phase 1, Phase 21 site๐Ÿ“ Shanghai Shanghai Chest Hospital ยท Tests: PD-1inhibitor, nab-paclitaxel + cisplatin, Radiotherapy Integrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer ๏ผˆRadiogenomics-Esophagus๏ผ‰ NCT07354295n/a1 site๐Ÿ“ Wuhan Shu Peng A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1) NCT05865002Phase 137 sites๐Ÿ“ Vijayawada๐Ÿ“ Visakhapatnam๐Ÿ“ Chandigarh Aurigene Discovery Technologies Limited ยท Tests: AUR107 PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer NCT06086457Phase 31 site๐Ÿ“ Beijing Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: Radiation, TP or PF regimen depended on investigator's choice., PD-1 inhibitor Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms NCT06687603NA5 sites๐Ÿ“ Aurora๐Ÿ“ Baltimore๐Ÿ“ Chapel Hill Case Comprehensive Cancer Center ยท Tests: EsoCheck, EsoGuard Lymphocyte-sparing Thoracic Radiotherapy for Esophageal Squamous Cell Carcinoma NCT06596954NA1 site๐Ÿ“ Shanghai Ruijin Hospital ยท Tests: lymphocyte-sparing radiotherapy, conventional radiotherapy Hypofractionated Definitive Chemoradiotherapy for Oesophageal Cancer NCT07632079Phase 27 sites๐Ÿ“ Amsterdam๐Ÿ“ Apeldoorn๐Ÿ“ Apeldoorn Academisch Medisch Centrum - Universiteit van Amsterdam (AMโ€ฆ ยท Tests: Hypofractionation, carboplatin + paclitaxel (CP) Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma NCT06718205Phase 21 site๐Ÿ“ Zhengzhou The First Affiliated Hospital of Zhengzhou University ยท Tests: Nimotuzumab, Sintilimab, Paclitaxel-albumin, Cisplatin Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer. NCT05624099Phase 21 site๐Ÿ“ Fuzhou Fujian Cancer Hospital ยท Tests: camrelizumab, Paclitaxel drugs, Platinum drug, Radiation A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal Cancer NCT06474468Phase 1, Phase 21 site๐Ÿ“ Jinan Shanghai Hengrui Pharmaceutical Co., Ltd. ยท Tests: SHR-A2102๏ผ›Adebrelimab๏ผ›Cisplatin A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors NCT07749586Phase 1, Phase 24 sites๐Ÿ“ New York๐Ÿ“ Huntersville๐Ÿ“ San Antonio Arvinas Inc. ยท Tests: ARV-6723, Pembrolizumab, SOC Precision Palliative Care for Patients With Advanced Esophageal Cancer NCT06787313n/a1 site๐Ÿ“ Shanghai Fudan University ยท Tests: precision palliative care Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA NCT07070466Phase 22 sites๐Ÿ“ Santa Monica๐Ÿ“ Boston Massachusetts General Hospital ยท Tests: Ivonescimab, 5-Fluorouracil, Oxaliplatin, Leucovorin Personalized Nutrition Counseling and Nutritional Status of Esophageal Cancer and HNSCC Patients Undergoing CCRT NCT06829095n/a1 site๐Ÿ“ New Taipei City Chang Gung Memorial Hospital Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow NCT03551951n/a1 site๐Ÿ“ Columbia University of Missouri-Columbia ยท Tests: Test for circulating tumor cells, DNA alterations A Study in Greece Observing How Patients With Stomach and Esophageal Cancer Are Diagnosed and Treated in Everyday Medical Practice NCT07800754n/a8 sites๐Ÿ“ Alexandroupoli๐Ÿ“ Athens๐Ÿ“ Athens AstraZeneca A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer NCT05563766Phase 27 sites๐Ÿ“ Palo Alto๐Ÿ“ Ann Arbor๐Ÿ“ Durham VA Office of Research and Development ยท Tests: Itraconazole
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy